8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 2, 2008

PSS WORLD MEDICAL, INC.

(Exact name of Registrant as specified in its charter)

Commission File Number: 0-23832

Florida	59-2280364
(State or other jurisdiction	(IRS Employer
of incorporation or organization)	Identification Number)
4345 Southpoint Blvd.
Jacksonville, Florida	32216
(Address of principal executive offices)	(Zip code)
Registrant’s telephone number, including area code	(904) 332-3000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item8.01 Other Events

Share Repurchase Authorization

On April 2, 2008, the Board of Directors for PSS World Medical Inc. (“the Company”) authorized the purchase of its outstanding common shares. Depending on current market conditions and other factors, the Company is authorized to repurchase up to a maximum of 5% of its total common stock, or approximately 3.1 million common shares, in the open market, privately negotiated transactions, and other transactions that will be disclosed publicly through filings with the Securities and Exchange Commission (SEC). This authorization is in addition to any shares remaining available under existing repurchase programs. As of Wednesday, April 2, 2008, the Company had approximately 61.9 million total issued and outstanding common shares.

A copy of this press release is filed with this Current Report as Exhibit 99.1 and is incorporated herein by reference.

Item9.01 Financial Statements and Exhibits.

Exhibit

Number Description

99.1 Press Release dated April 7, 2008 with respect to the Registrant’s share repurchase authorization.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: April 7, 2008

PSS WORLD MEDICAL, INC.

/s/ David M. Bronson

Name: David M. Bronson

Title: Executive Vice President and Chief Financial Officer

EXHIBIT INDEX

99.1 Press Release dated April 7, 2008 with respect to the Registrant’s share repurchase authorization.

EX-99

N    E    W     S        R     E     L     E     A     S     E

Contacts:
For investors:	Robert C. Weiner	For media:	Brian C. Kosoy
	Vice President, Investor Relations		Public Relations
	904-332-3287		904-332-4175

PSS WORLD MEDICAL BOARD OF DIRECTORS AUTHORIZES

PURCHASE OF 5% OF TOTAL COMMON SHARES

Jacksonville, Florida (April 7, 2008) – PSS World Medical, Inc. (NASDAQ GS:PSSI) announced today that its Board of Directors has authorized the purchase of up to 5% of its total outstanding common shares.

The Company is authorized to repurchase, depending on current market conditions and other factors, up to a maximum of 5% of its total common stock, or approximately 3.1 million common shares, in the open market, privately negotiated transactions, and other transactions disclosed publicly through filings with the Securities and Exchange Commission. This authorization is in addition to any shares remaining available under existing repurchase programs. Such repurchases will be made in compliance with applicable rules and regulations and may be discontinued at any time. As of Wednesday, April 2, 2008, the Company had approximately 61.9 million total issued and outstanding common shares.

PSS World Medical, Inc. is a national distributor of medical products to physicians and elder care providers through its two business units. Since its inception in 1983, PSS has become a leader in the two market segments that it serves with a focused market approach to customer services, a consultative sales force, strategic acquisitions, strong arrangements with product manufacturers and a unique culture of performance.

-END-